Navigation Links
MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
Date:7/21/2010

DALLAS, July 21, 2010 /PRNewswire/ -- According to the new market research report "Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)", published by MarketsandMarkets (http://www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion due to rising demand from U.S. and Europe.

Browse in-depth TOC on Bioinformatics Market. Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

The bioinformatics platforms market is growing at a significant pace with the increasing demand from U.S. and Europe. This trend is supported by the increasing demand for sequencing platforms with increasing life science research using techniques such as gene expression analysis, sequence analysis, and protein expression analysis.

Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality in the current competitive scenario, as there is little scope for price escalation and product differentiation.

    SCOPE AND FORMAT

    - The report analyzes the global bioinformatics market into respective
      segments:

    - Bioinformatics platforms
    - Content/knowledge management tools
    - Bioinformatics services
    - Bioinformatics applications

Analyst Briefing Presentation On Bioinformatics Market - Advanced Technologies, Global Forecast And Winning Imperatives (2009 - 2014) To Be Held On 5th Aug 2010

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on Bioinformatics Market ( http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html) - Advanced Technologies, Global Forecast And Winning Imperatives (2009 - 2014) to be held on 5th Aug 2010.

To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/bioinformatics-market.asp

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: sales@marketsandmarkets.com
    http://www.marketsandmarkets.com
    http://marketsandmarkets.wordpress.com/
    http://marketsandmarkets.blogspot.com/


'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
2. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
3. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
4. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
5. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
6. European cooperation ensures global leadership in microelectronics
7. United Nations' World Population Day Calls Attention to Key Global Issues
8. Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential
9. China Cord Blood Corporation Joins Russell Global Index
10. DuPont Leader: Global Demand for Renewable Innovations Growing
11. Reportlinker Adds Global Nucleic Acid Testing Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/23/2017)... and NEW YORK , ... Lumeon , a leading digital health company, ... a provider of telemedicine and remote patient monitoring, ... for telemedicine reimbursements.  DN Telehealth ... patients, in real-time, extending consultations beyond a physical ...
(Date:2/23/2017)... TORONTO , Feb. 23, 2017 /PRNewswire/ - The ... Institute for Cancer Research (OICR) are pleased to report ... Series A financing, with Johnson & Johnson Innovation – ... investors include venture groups HealthCap, TPG Biotechnology Partners, and ... ...
(Date:2/23/2017)... SEATTLE , Feb. 23, 2017  Seattle,s upscale Capitol ... like a strange place for a head lice treatment salon ... nestled between a Tuscan restaurant and a French bistro on ... it,s perfect. "We aren,t just any old lice clinic, we ... to feel comfortable, and release some of the stigma associated ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
Breaking Biology News(10 mins):